Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ovarian Neoplasms

Free Subscription 13.10.2025 2 BMC Cancer 1 Br J Cancer 1 Hum Pathol 1 Int J Cancer 6 Int J Gynecol Pathol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. AMMOUS-BOUKHRIS N, Abdelmaksoud-Dammak R, Ben Kridis W, Ben-Ayed-Guerfali D, et al
   Germline and somatic mutational variants of Tunisian high grade serous ovarian cancer identified by next-generation sequencing.
   BMC Cancer. 2025;25:1542.
   PubMed         Abstract available
   
   
2. WU H, Lin R, Hong L
   ACOXL-AS1's pan-cancer dynamics and its proliferative impact on endometrial endometrioid carcinoma.
   BMC Cancer. 2025;25:1522.
   PubMed         Abstract available
   
   

   
   Br J Cancer

3. DURAN GE, Wang YC, Moisan F, Francisco EB, et al
   Editorial Expression of Concern: Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition.
   Br J Cancer. 2025 Oct 6. doi: 10.1038/s41416-025-03231.
   PubMed        
   
   

   
   Hum Pathol

4. QIN L, Lin W, Huang S, Zheng W, et al
   High-grade endometrioid carcinomas with pilomatrix-like features lacking CTNNB1 Mutations: Clinicopathologic characteristics and novel molecular events.
   Hum Pathol. 2025;164:105928.
   PubMed         Abstract available
   
   

   
   Int J Cancer

5. KAUPPINEN AK, Olkinuora AP, Mecklin JP, Peltomaki PT, et al
   Molecular analysis of the evolutionary history of endometrial and ovarian carcinoma in Lynch syndrome.
   Int J Cancer. 2025 Aug 7. doi: 10.1002/ijc.70074.
   PubMed         Abstract available
   
   

   
   Int J Gynecol Pathol

6. BAKKAR R, Afkhami M, Balzer B, Maluf H, et al
   PTCH1::GLI1 Fusion Tumors of the Ovary: A Clinicopathologic Study of 3 Cases.
   Int J Gynecol Pathol. 2025;44:507-518.
   PubMed         Abstract available
   
   
7. HUVILA J, Talhouk A, Gilks B, McAlpine JN, et al
   Histotype and Grade Are of Prognostic Significance in the No Specific Molecular Profile Molecular Subtype of Endometrial Carcinoma But Not in POLE mut, MMRd, or p53abn Endometrial Carcinomas: Results From a 2478 Case Series and a Systematic Review of
   Int J Gynecol Pathol. 2025;44:478-484.
   PubMed         Abstract available
   
   
8. SEIDMAN JD, Krishnan J
   Characterization of High-grade Serous Carcinoma Involving the Ovarian Surface Epithelium-peritoneal Junction.
   Int J Gynecol Pathol. 2025;44:532-538.
   PubMed         Abstract available
   
   
9. MIRKOVIC J, Olkhov-Mitsel E, Nofech-Mozes S, Fadare O, et al
   Napsin-A Expression in Mesonephric and Mesonephric-like Adenocarcinomas: Implications for Distinction From Clear Cell Carcinoma.
   Int J Gynecol Pathol. 2025;44:526-531.
   PubMed         Abstract available
   
   
10. LIU L, Storino M, Chen YS, Walker A, et al
    Mesonephric and Mesonephric-like Adenocarcinomas of the Gynecologic Tract: A Case Series and a Review of the Literature.
    Int J Gynecol Pathol. 2025;44:553-560.
    PubMed         Abstract available
    
    
11. LIN LH, Irshaid L, Matulonis UA, Kolin DL, et al
    Validation of Tumor Budding as a Prognostic Factor in Ovarian Clear Cell Carcinoma Using an Independent Cohort.
    Int J Gynecol Pathol. 2025;44:519-525.
    PubMed         Abstract available
    
    

    
    PLoS One

12. ADISU MA, Habtie TE, Kitaw TA, Gessesse AD, et al
    The rising burden of female cancer in Ethiopia (2000-2021) and projections to 2040: Insights from the global burden of disease study.
    PLoS One. 2025;20:e0333787.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.